STEM vs. NVX, ULBI, GWH, ELVA, CBAT, SES, FLUX, LLAP, MVIS, and TRUE
Should you be buying Stem stock or one of its competitors? The main competitors of Stem include NOVONIX (NVX), Ultralife (ULBI), ESS Tech (GWH), Electrovaya (ELVA), CBAK Energy Technology (CBAT), SES AI (SES), Flux Power (FLUX), Terran Orbital (LLAP), MicroVision (MVIS), and TrueCar (TRUE). These companies are all part of the "computer and technology" sector.
NOVONIX (NASDAQ:NVX) and Stem (NYSE:STEM) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability, community ranking and analyst recommendations.
NOVONIX has a net margin of 0.00% compared to NOVONIX's net margin of -30.42%. Stem's return on equity of 0.00% beat NOVONIX's return on equity.
In the previous week, Stem had 1 more articles in the media than NOVONIX. MarketBeat recorded 3 mentions for Stem and 2 mentions for NOVONIX. Stem's average media sentiment score of 0.71 beat NOVONIX's score of 0.45 indicating that NOVONIX is being referred to more favorably in the media.
Stem received 26 more outperform votes than NOVONIX when rated by MarketBeat users.
NOVONIX has higher earnings, but lower revenue than Stem.
0.1% of NOVONIX shares are held by institutional investors. Comparatively, 61.6% of Stem shares are held by institutional investors. 23.7% of NOVONIX shares are held by insiders. Comparatively, 9.1% of Stem shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Stem has a consensus target price of $5.96, suggesting a potential upside of 258.90%. Given NOVONIX's higher probable upside, analysts clearly believe Stem is more favorable than NOVONIX.
NOVONIX has a beta of 3.3, suggesting that its stock price is 230% more volatile than the S&P 500. Comparatively, Stem has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500.
Summary
NOVONIX beats Stem on 8 of the 14 factors compared between the two stocks.
Get Stem News Delivered to You Automatically
Sign up to receive the latest news and ratings for STEM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
